Angle Health raises $134 million in Series B funding to enhance its AI-native health benefits platform amidst a transformative U.S. healthcare landscape.
Target Company Overview
Angle Health is a pioneering firm that has introduced the first vertically integrated AI platform for healthcare benefits. Recently, the company secured $134 million in an oversubscribed Series B funding round, which was led by Portage and included participation from several prominent investors such as Blumberg Capital, Mighty Capital, PruVen Capital, and Y Combinator. This funding, which consists of both debt and equity, elevates the total capital raised by Angle to nearly $200 million, aimed at expanding operations to cater to the growing demand for alternative health plan offerings.
Angle Health is at the forefront of a significant transformation within the U.S. healthcare industry, which is valued at $4 trillion. The ongoing changes in this industry reflect an urgent need for innovation, particularly as the Affordable Care Act (ACA) premiums are expected to rise by over 15%, marking the steepest increase since 2018. Angle Health is successfully providing AI-driven solutions that help streamline costs and enhance patient outcomes while delivering tangible value across the healthcare system.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview: U.S. Healthcare Sector
The U.S. healthcare industry is undergoing a substantial shift characterized by a demand for cost-efficient healthcare solutions and streamlined operations. Recent scrutiny on billing practices from regulators
Similar Deals
Oak HC/FT, General Catalyst → Chai Discovery
2025
Oak HC/FT → Chai Discovery
2025
Redpoint Ventures → Function Health
2025
Five Elms Capital → Ritten
2025
Reach Capital → Manifold
2025
ARCH Venture Partners, GV (Google Ventures) → Pelage Pharmaceuticals
2025
Portage
invested in
Angle Health
in 2025
in a Series B deal
Disclosed details
Transaction Size: $134M